DELANEY VASQUEZ: Open Payments
NPI 1245803634 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 19 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $271 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Genentech USA, Inc. | 2 | $35 |
| Genmab U.S., Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novocure Inc. | 1 | $20 |
| Caris MPI, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: PLUVICTO, KEYTRUDA, Tivdak, CARVYKTI, VENCLEXTA, FRUZAQLA, Optune Lua (NovoTTF-200T), MI CANCER SEEK.
Industry payments across KY — which companies pay providers there.
